Medindia

X

Japanese Encephalitis Vaccine Launched in India

by Kathy Jones on  September 14, 2012 at 8:53 PM Indian Health News   - G J E 4
Austrian biotech company Intercell announced the launch of its Japanese encephalitis vaccine in India where it will be manufactured by its partner, Biological E in Hyderabad.
 Japanese Encephalitis Vaccine Launched in India
Japanese Encephalitis Vaccine Launched in India
Advertisement

The vaccine will be marketed under the brand name Jeev and will cost around Rs 985. Intercell revealed that it hoped the launch will help the company achieve a profit in the second quarter and added that it was also looking get approval to market the vaccine in other Asian countries.

Advertisement
Jeev is already available in western markets including Europe, North America, Australia and Singapore where it is marketed under the brand name Ixario.

Stating that it was a major step forward for his company, Intercell Chief Executive Thomas Lingelbach said, "We have taken a major step forward in achieving our goal of rolling out this Japanese Encephalitis vaccine in endemic countries with a high medical need in order to protect children and adults."

Source: Medindia
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All